Medrolin 50 mg

Medrolin 50 mg | INDICATIONS AND USES

Mebhydrolin Napadisylate is indicated in-

Allergic disease or symptoms such as urticaria
Pruritus of various origin
Eczema
Itching
Drug rash
Insect bites
Allergic conjunctivitis
Dermatitis of nutritional origin
Hay fever
Vasomotor rhinitis
Allergic asthma.

Medrolin 50 mg | PHARMACOLOGY

Mebhydrolin diminishes or abolishes the main actions of histamine in the body by blocking of histamine receptors.

Medrolin 50 mg | DOSAGE & ADMINISTRATION

Adults and children over 10 years: 2-6 tablets dailyChildren-

5-10 years: 2-4 tablets daily
2-5 years: 1-3 tablets daily
Up to 2 years: 1-2 tablets daily

Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.

Medrolin 50 mg | DRUG INTERACTIONS

The effects of atropine and tricyclic anti-depressants may be enhanced by Mebhydrolin. It may mask the warning symptoms of damage caused by ototoxic drugs.

Medrolin 50 mg | SIDE EFFECTS

Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.

Medrolin 50 mg | USE DURING PREGNANCY AND LACTATION

Safety in pregnancy and lactation has not been established.

Medrolin 50 mg | PRECAUTIONS & WARNINGS

The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.

Medrolin 50 mg | USE IN SPECIAL POPULATIONS

Safety in pregnancy and lactation has not been established.

Medrolin 50 mg | THERAPEUTIC CLASS

Sedating Anti-histamine

Medrolin 50 mg | STORAGE CONDITIONS

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.